Mangalam Drugs & Organics Balance Sheet Health
Financial Health criteria checks 3/6
Mangalam Drugs & Organics has a total shareholder equity of ₹1.3B and total debt of ₹945.3M, which brings its debt-to-equity ratio to 71.4%. Its total assets and total liabilities are ₹3.8B and ₹2.5B respectively.
Key information
71.4%
Debt to equity ratio
₹945.33m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹56.62m |
| Equity | ₹1.32b |
| Total liabilities | ₹2.48b |
| Total assets | ₹3.81b |
Recent financial health updates
Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29
These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01
Recent updates
Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01Financial Position Analysis
Short Term Liabilities: MANGALAM's short term assets (₹2.3B) exceed its short term liabilities (₹2.1B).
Long Term Liabilities: MANGALAM's short term assets (₹2.3B) exceed its long term liabilities (₹391.9M).
Debt to Equity History and Analysis
Debt Level: MANGALAM's net debt to equity ratio (67.1%) is considered high.
Reducing Debt: MANGALAM's debt to equity ratio has increased from 59.2% to 71.4% over the past 5 years.
Debt Coverage: MANGALAM's debt is well covered by operating cash flow (41.8%).
Interest Coverage: Insufficient data to determine if MANGALAM's interest payments on its debt are well covered by EBIT.